Mentions
Extended reach
Total likes
Video views
AI synopsis
The group shows strong interest and moderate agreement with the study's potential, exemplified in posts that highlight the importance of skin biopsies for differential diagnosis and in comments about training in neurology, which reflect deeper engagement. The tone suggests anticipation of clinical impact, such as the connection to early Parkinson’s symptoms and neurodegenerative disease management.
Most discussions show support or recognition of the article’s findings and potential, especially acknowledging the significance of skin-based biomarkers.
Participants display high interest, referencing biomarker detection, clinical applications, and related neurological conditions, indicating engagement with the research.
Posts involve some degree of reflection, such as training in neurology or drawing parallels to COVID-19, suggesting moderate but meaningful engagement.
The discussions hint at the research's potential to influence diagnostic approaches and clinical practice, though mostly in an exploratory or optimistic context.
Covid➡️ #Longcovid ➡️Parkinson’s disease❓”Parallels between the early Parkinson's symptoms outlined above and the symptoms reported by long COVID patients are undeniable.” Skin biopsy biomarker Parkinson’s https://t.co/UFW8clPRUy https://t.co/Jql89VId9i
Feeling incredibly lucky to be training in #autonomic neurology with this group @BIDMChealth. "Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease." https://t.co/rLRTkrpbzI
RT @PaulBeachDOPhD: Feeling incredibly lucky to be training in #autonomic neurology with this group @BIDMChealth. "Cutaneous α-Synuclein Si…
RT @mryoung151: Covid➡️ #Longcovid ➡️Parkinson’s disease❓”Parallels between the early Parkinson's symptoms outlined above and the symptoms…
RT @mryoung151: Covid➡️ #Longcovid ➡️Parkinson’s disease❓”Parallels between the early Parkinson's symptoms outlined above and the symptoms…
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease #neuropath https://t.co/xDHzoMzyud
This episode discusses a study on identifying skin-based biomarkers, involving phosphorylated synuclein, to accurately differentiate between Multiple System Atrophy and Parkinson's Disease with 90% accuracy. Skin…
The study focused on identifying a unique skin-based biomarker involving phosphorylated synuclein to differentiate MSA and Parkinson Disease. Detection of phosphorylated synuclein deposits in skin biopsies shows promise…
RT @mryoung151: Covid➡️ #Longcovid ➡️Parkinson’s disease❓”Parallels between the early Parkinson's symptoms outlined above and the symptoms…
RT @mryoung151: Covid➡️ #Longcovid ➡️Parkinson’s disease❓”Parallels between the early Parkinson's symptoms outlined above and the symptoms…
Covid➡️ #Longcovid ➡️Parkinson’s disease❓”Parallels between the early Parkinson's symptoms outlined above and the symptoms reported by long COVID patients are undeniable.” Skin biopsy biomarker Parkinson’s https://t.co/UFW8clPRUy https://t.co/Jql89VId9i
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease #neuropath https://t.co/xDHzoMzyud
RT @PaulBeachDOPhD: Feeling incredibly lucky to be training in #autonomic neurology with this group @BIDMChealth. "Cutaneous α-Synuclein Si…
Feeling incredibly lucky to be training in #autonomic neurology with this group @BIDMChealth. "Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease." https://t.co/rLRTkrpbzI
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease https://t.co/0g7allo5LG